Stay updated on Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial
Sign up to get notified when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.
Latest updates to the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.2%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedDifference0.2%
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements in the latest release.SummaryDifference0.1%
- Check32 days agoNo Change Detected
- Check46 days agoChange DetectedThe study has expanded to include 54 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.3%
- Check51 days agoChange DetectedDifference0.2%
- Check53 days agoChange DetectedDifference0.2%
Stay in the know with updates to Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.